European Medicines Agency: AstraZeneca vaccine may have potential link with thrombosis

According to Bloomberg news on April 6, according to the Italian newspaper Il Messaggero, the European Medicines Agency (EMA) believes that AstraZeneca vaccine is potentially linked to blood clots.

Due to concerns about the possible risk of blood clots after vaccination, Denmark, Germany, France, Italy and other countries have announced the suspension of the use of AstraZeneca vaccine in mid-March. Subsequently, the WHO stated on March 17 that given that the vaccine's anti-epidemic effect is greater than the potential risk, it is still recommended to continue vaccination.

The European Medicines Agency issued preliminary findings on March 18, stating that the AstraZeneca vaccine "benefits outweigh the risks," but it does not rule out that it is related to a very small number of thrombosis cases. Subsequently, France, Germany and many other countries resumed vaccination of this vaccine one after another.